Skip to main content
Signal8

South Cone Investments Limited Partnership

SEC insider (Form 3/4/5 filer). CIK 0001876412. 10% Owner at Rani Therapeutics Holdings, Inc. (RANI). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 21, 2025. Located in SANTIAGO, F3.

Companies South Cone Investments Limited Partnership has filed insider reports for

  • Rani Therapeutics Holdings, Inc. (RANI): 10% Owner
South Cone Investments Limited Partnership profile photo

South Cone Investments Limited Partnership

CIK: 0001876412

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Rani Therapeutics Holdings, Inc. logo
RANI

Rani Therapeutics Holdings, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Oct 21, 2025
    Sale
    Indirect
    4M shares at avg. $2.77$11.1M
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Oct 20, 2025
    Sale
    Indirect
    1.9M shares at avg. $2.41$4.6M
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Oct 15, 2024
    Sale
    Indirect
    3.3M shares at avg. $2.55$8.4M
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Oct 15, 2024
    Sale
    Indirect
    523.7K shares at avg. $3.26$1.7M

1-4 of 4